Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Cites (216)

Items 201–216 of 216

1. Designing a new dimerized anti human TNF‐α aptamer with blocking activity
   Kazem Mashayekhi, Ali Ganji, Mojtaba Sankian · 2020 · Biotechnology Progress
2. Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats
   Amany A. Abdin, Mahmoud S. Abd El-Halim, Sabiha E. Hedeya, Amira A. El Saadany · 2011 · European Journal of Pharmacology
3. Simvastatin protects the heart against ischemia reperfusion injury via inhibiting HMGB1 expression through PI3K/Akt signal pathways
   Qian-Feng Han, Lei Wu, Yanhong Zhou, Lanhua Wang, Deyong Zhang, Tao Liu, Heng-Chen Yao · 2015 · International Journal of Cardiology
4. Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins
   Αthanasios Katsargyris, Chris N. Klonaris, Sotirios Tsiodras, E Bastounis, Athanasios G. Giannopoulos, Stamatios E Theocharis · 2011 · Vascular
5. V617F‐independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease
   Hamid Asadzadeh‐Aghdaei, Kazem Mashayekhi, Khadijeh Koushki, Pedram Azimzadeh, Mohammad Rostami‐Nejad, Davar Amani, Vahid Chaleshi, Saeed Mohammadian Haftcheshmeh, Amirhossein Sahebkar, Mohammad Reza Zali · 2019 · Journal of Cellular Biochemistry
6. Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice
   Yumei Ye, Sven Nylander, Yochai Birnbaum · 2017 · Cardiovascular Drugs and Therapy
7. Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting
   Young‐Cheoul Doo, Sang-Jin Han, Sung-Woo Han, Woo-Jung Park, Seung‐Hyuk Choi, Goo‐Yeong Cho, Kyung-Soon Hong, Kyoo‐Rok Han, Namho Lee, Dong‐Jin Oh et al. · 2005 · Clinical Cardiology
8. Therapy to reduce risk of coronary heart disease
   Daniel James Rader · 2003 · Clinical Cardiology
9. The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity
   Gudrun Sigrid Ulrich-Merzenich, Heike Zeitler · 2013 · Expert Opinion on Therapeutic Targets
10. Statins – are they potentially useful in rheumatology?
    Aneta Bielińska, Piotr Głuszko · 2007 · Polskie Archiwum Medycyny Wewnętrznej
11. [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
    Wei CAI, Jun Fang, Zhao-yang CHEN, Yun-ling LIN, Li-ming WU, Lianglong Chen · 2010 · PubMed
12. Effect of Targeting Mitogen-Activated Protein Kinase on Cardiac Remodeling in Rats
    Azza Baraka, Maher Mikhail, Aida Ahmed Said Guemei, Samar El Ghotny · 2009 · Journal of Cardiovascular Pharmacology and Therapeutics
13. Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date
    Christopher P. Nelson, Clett Erridge · 2018 · Immunogenetics
14. Optimization of Cloning Conditions for High-level Production of Recombinant Mouse Interleukin-2 in Escherichia coli
    Arezou Abdi, Mitra Hosseinpour, Kazem Mashayekhi, Mohammad Javad Mousavi, Seyedeh Elham Badiee Kheirabadi, Mojtaba Sankian · 2019 · Research in Molecular Medicine
15. A Convenient Method for Solubilization and Refolding Recombinant Proteins: An Experience from Recombinant Mouse TGF-β1
    Fahimeh Maleki, Kazem Mashayekhi, Seyedeh Elham Badiee Kheirabadi, Mohammad Javad Mousavi, Mojtaba Sankian · 2020 · Research in Molecular Medicine
16. 1.P.153 Influence of pravatatin and plasma lipids on clinical events, in the West of Scotland Coronary Prevention Study (WOSCOPS)
    C.J. Packard, John D. Norrie, Ian Ford, Stuart M. Cobbe, J. Shepherd · 1997 · Atherosclerosis